Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Title
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
Authors
Keywords
Amyloid, Alzheimer's disease, Biomarker, Positron emission tomography, Development, Neuroimaging, Early diagnosis, Biomarker-based diagnosis, Clinical validity, 5-Phases
Journal
NEUROBIOLOGY OF AGING
Volume 52, Issue -, Pages 214-227
Publisher
Elsevier BV
Online
2017-03-17
DOI
10.1016/j.neurobiolaging.2016.07.012

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started